New patent for Mallinckrodt Hosp drug INOMAX

Annual Drug Patent Expirations for INOMAX Inomax is a drug marketed by Mallinckrodt Hosp and is included in one NDA. It is available from one supplier. There are fifteen patents…

Source


Comments are closed.

Biotechblog